| Marquitta Breanna Merkison, AUD | |
|
2300 M St Nw, 4th Floor, Washington, DC 20037-1434 | |
| (202) 741-3275 | |
| (202) 741-3277 |
| Full Name | Marquitta Breanna Merkison |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 2300 M St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154634749 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | AUD0000112 (District Of Columbia) | Secondary |
| 231H00000X | Audiologist | 01201 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marquitta Breanna Merkison, AUD 2300 M St Nw, 4th Floor, Washington, DC 20037-1434 Ph: (202) 741-3275 | Marquitta Breanna Merkison, AUD 2300 M St Nw, 4th Floor, Washington, DC 20037-1434 Ph: (202) 741-3275 |
News Archive
A new study has found that women are more likely than men to develop heart failure or die within five years after suffering a heart attack.
Foamix Ltd., a leading developer of topical foams for dermatology and gynecology, announced today that it has been awarded US Patent #7575739 pertaining to its foam technology. The patent covers unique foam compositions, suitable for the treatment of heat and chemical burns, wounds, bacterial, fungal and viral infections.
The results of the research conducted in the ICAS Culiacán reveal that at least 10 percent of the fresh cheese, sausages and meats sold in markets and on the street may be contaminated.
According to British researchers breathing in heavy traffic fumes can trigger a heart attack. Heart attack risk is raised for about six hours post-exposure and goes down again after that, researchers found. They say in the British Medical Journal that pollution probably hastens rather than directly cause attacks. But repeated exposure is still bad for health, they say, substantially shortening life expectancy, and so the advice to people remains the same - avoid as far as is possible.
ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.
› Verified 7 days ago
Sheela L Stuart, PHD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-884-5600 | |
Karen Tal Woolman, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5627 | |
Mrs. Elise Ney, M.A, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 4910 Massachusetts Ave Nw, Ste 29, Washington, DC 20016 Phone: 202-362-4300 | |
Ashley King, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2300 M St Nw, Washington, DC 20037 Phone: 410-991-4749 | |
Dr. Claire Bernstein, PH.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 800 Florida Ave Ne, Washington, DC 20002 Phone: 301-509-0722 | |
Hearing 4life Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3301 New Mexico Ave Nw Ste 125, Washington, DC 20016 Phone: 202-621-6374 | |
Kelsey Ann Ambrose, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2300 M St Nw Fl 4, Washington, DC 20037 Phone: 202-741-3275 |